12 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 12 of 12 clinical reviews.
A guide for caregivers on giving metformin to adolescents aged 12 to 17, covering dosing schedules, titration, side-effect management, missed doses, and when to call the prescriber.
A guide covering how metformin affects school performance, physical activity, sports participation, and daily scheduling for adolescents aged 12 to 17.
A clinical guide to metformin use in geriatric patients covering cognitive engagement, physical activity, exercise-related lactic acidosis risk, renal monitoring, and dose adjustments for adults 65 and older.
Step-by-step guidance for caregivers administering metformin to children under age 12, including dosing schedules, liquid vs. Tablet forms, side-effect management, and red-flag symptoms requiring urgent care.
Complete guidance for caregivers administering metformin to adults aged 65 and older: dosing, kidney monitoring, hypoglycemia risk, drug interactions, and when to hold the drug.
A clinical review of how metformin affects growth, puberty, bone density, cognitive development, and long-term hormonal health in adolescents aged 12 to 17, with dosing guidance and safety data from named trials and guidelines.
A guide to off-label metformin use in adolescents aged 12 to 17, covering PCOS, prediabetes, obesity, insulin resistance, safety, and dosing protocols with primary-source citations.
A guide to metformin use in patients aged 65 and older, covering pharmacokinetics, renal dosing, cognitive effects, frailty considerations, and current guideline recommendations.
A guide to off-label metformin use in geriatric patients aged 65 and older, covering longevity, cancer prevention, cognitive protection, PCOS, and weight management, with current dosing guidance and renal safety thresholds.
A guide to metformin's developmental effects in children under 12, covering growth, cognition, puberty, and B12 status, with citations from clinical trials and FDA labeling.
A guide to managing metformin use in children under 12 at school and during physical activity, covering GI side effects, hypoglycemia risk, exercise interactions, and communication with school staff.
A clinical deep-dive into off-label metformin use in children younger than 12, covering evidence, dosing, risks, and when prescribers consider it appropriate.